Zdrowie i gospodarka · 25/05/2021
FDA Issues Final Guidance on Pediatric Studies for Molecularly Targeted Oncology Drugs
The FDA has released a final guidance for industry on pediatric studies for molecularly targeted oncology drugs, aiming to accelerate the development of promising treatments for pediatric patients, in accordance with the FDA Reauthorization Act of 2017.
Source: Federal Register — Food and Drug AdministrationOpen original release →